⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14627140 | 1.00 | — | — | |
| SCHEMBL29728550 | 0.90 | LMNA (0.48) | — | |
| Pentabamate SCHEMBL636717 | 0.85 | LMNA (0.44) | — | |
| SCHEMBL29728537 | 0.84 | LMNA (0.40) | — | |
| Methacrylic Acid SCHEMBL21483482 | 0.83 | TDP1 (0.40) | — | |
| SCHEMBL18043494 | 0.82 | — | — | |
| SCHEMBL28623543 | 0.82 | — | — | |
| SCHEMBL8755732 | 0.82 | — | — | |
| SCHEMBL28623541 | 0.82 | — | — | |
| SCHEMBL14592888 | 0.82 | LMNA (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112552207-A | Production method of anisyl nitrile | 郑州科旷生物科技有限公司 | 2021-03-26 | — | — | CN | claimed |
| EP-1906945-B1 | HCV INHIBITORS | VIROBAY INC (US) | 2015-08-05 | — | — | EP | claimed |
| EP-2431379-A2 | HCV inhibitors | Virobay, Inc. (US) | 2012-03-21 | — | — | EP | claimed |
| US-20100266537-A1 | HCV INHIBITORS | VIROBAY, INC. (US) | 2010-10-21 | — | — | US | claimed |
| US-7608592-B2 | HCV inhibitors | VIROBAY, INC. (US) | 2009-10-27 | — | — | US | claimed |
| EP-1906945-A4 | HCV INHIBITORS | VIROBAY INC (US) | 2009-07-15 | — | — | EP | claimed |
| WO-2008086053-A1 | HCV INHIBITORS | VIROBAY, INC. (US) | 2008-07-17 | — | — | WO | claimed |
| US-20080161254-A1 | HCV INHIBITORS | VIROBAY, INC. (US) | 2008-07-03 | — | — | US | claimed |
| EP-1906945-A2 | HCV INHIBITORS | Virobay, Inc. (US) | 2008-04-09 | — | — | EP | claimed |
| US-20070054864-A1 | 1-[2S-(3-Tert-butylureido)-3,3-dimethylbutyryl]-4R-(7-methoxy-2-pyrazol-1-yl-quinolin-4-yloxy)-pyrrolidine-2S-carboxylic acid (1S-cyclopropylaminooxalylbutyl)amide, for example; useful in treating hepatitis C infections | QUEST DIAGNOSTICS INVESTMENTS LLC | 2007-03-08 | — | — | US | claimed |
| WO-2007005838-A2 | HCV INHIBITORS | VIROBAY, INC. (US) | 2007-01-11 | — | — | WO | claimed |
| WO-2024096066-A1 | CYCLIC PEPTIDE DERIVATIVE COMPOSITION FOR TREATING OR PREVENTING CENTRAL NERVOUS SYSTEM INJURY/DISEASE | 第一工業製薬株式会社 | 2024-05-10 | — | — | WO | disclosed |
| WO-2024094637-A1 | PROCESS FOR THE PREPARATION OF CYCLIC KETONES | ARXADA AG (CH) | 2024-05-10 | — | — | WO | disclosed |
| WO-2024096067-A1 | CYCLIC PEPTIDE DERIVATIVE COMPOSITION FOR TREATING OR PREVENTING NEUROPATHIC PAIN AND/OR INFLAMMATORY PAIN | 第一工業製薬株式会社 | 2024-05-10 | — | — | WO | disclosed |
| EP-4361148-A1 | HETEROCYCLOALKYL-SUBSTITUTED POLYHETEROAZOLE DERIVATIVE AS MEDICAL DRUG FOR TREATMENT AND/OR PREVENTION OF RS VIRUS INFECTIOUS DISEASE | Albius Sciences Alpha Private Limited (SG) | 2024-05-01 | — | — | EP | disclosed |
| EP-0122202-B1 | TETRA-ALKYL-2,2,5,5-CYCLOHEXANON-4-OL-1 AND ITS SULFONATED DERIVATIVES, PROCESS AND INTERMEDIATES FOR ITS PREPARATION AND ITS USE IN THE SYNTHESIS OF CIS-CYCLOPROPANLACTONES | ROUSSEL-UCLAF (FR) | 1987-06-16 | — | — | EP | disclosed |
| US-4610826-A | INTERMEDIATES FOR FUNGICIDES | ROUSSEL UCLAF (FR) | 1986-09-09 | — | — | US | disclosed |
| WO-1984004090-A1 | NEW TETRA-ALKYL-2, 2, 5, 5-CYCLOHEXANONE-4 ol-1 AND SULPHONYLATED DERIVATIVES THEREOF, PREPARATION INTERMEDIARIES AND PROCESS AND THEIR APPLICATION TO THE SYNTHESIS OF CYCLOPROPANIC CIS LACTONES | ROUSSEL UCLAF (FR) | 1984-10-25 | — | — | WO | disclosed |
| EP-0122202-A2 | Tetra-alkyl-2,2,5,5-cyclohexanon-4-ol-1 and its sulfonated derivatives, process and intermediates for its preparation and its use in the synthesis of cis-cyclopropanlactones | ROUSSEL-UCLAF (FR) | 1984-10-17 | — | — | EP | disclosed |
| US-4207235-A | Selective epoxidation of steroidal bromohydrins | SYNTEX (U.S.A.) INC. (US) | 1980-06-10 | — | — | US | disclosed |